Most employers have little idea what the pharmacy benefit managers they hire do with the money they exchange for the ...

Perioperative chemotherapy may be underused in patients with stage II-III esophageal cancer, according to researchers.

Gilead has made the decision to withdraw the accelerated approval of Trodelvy (sacituzumab govitecan) for advanced urothelial cancer in the United States.

Five-fraction SBRT is “a robust and viable alternative” to conventionally or moderately fractionated radiotherapy for prostate cancer, researchers say.

The policy of billing for patient portal messages changes patient expectations and can impact the patient-physician ...

An analysis of AYA cancer survivors in the US revealed “a substantial population of aging, long-term cancer survivors,” according to researchers.

The FDA has approved Vyloy (zolbetuximab-clzb) in combination with chemotherapy to treat advanced gastric or GEJ cancer.

Updated results from the CheckMate 274 trial support the use of adjuvant nivolumab as standard care for high-risk muscle-invasive urothelial carcinoma, according to researchers.

Psilocybin-assisted psychotherapy “has the potential to be a comprehensive mental health treatment for patients with cancer,” ...

Nurses were more likely than other health care workers to favor using AI-generated responses to patient portal messages.

Exposure to radon levels, even below current recommended levels, heightens the risk for childhood leukemia, a study suggests.

The 5-year overall survival rate was 91.2% in patients diagnosed with hematologic malignancies during pregnancy and 90.3% in ...